HRT receives a $3.42M grant from Purdue Pharma

Harm Reduction Therapeutics’ work to develop and sell a low cost, over-the-counter naloxone nasal spray is now rapidly moving forward thanks to a $3.42M grant from Purdue Pharma L.P. We are a nonprofit pharmaceutical company working to break down price and access barriers by bringing naloxone over-the-counter (OTC) at the lowest possible price. These funds are an important step towards our goal of making low cost OTC naloxone as widely available as possible

Read More
Michael Hufford